Thomas M. Bulle

Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.

Sam Ellis, Michel Vandormael, Michael J. Cowley et al. · Circulation · 1990 · 1.3K citations

Medicine, Cardiology, Surgery +17

A Randomized Trial to Evaluate the Relative Protection Against Post-Percutaneous Coronary Intervention Microvascular Dysfunction, Ischemia, and Inflammation Among Antiplatelet and Antithrombotic Agents

C. Michael Gibson, David A. Morrow, Sabina A. Murphy et al. · Journal of the American College of Cardiology · 2006 · 122 citations

Medicine, Cardiology, Pharmacotherapy +14

Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty?

Michael J. Cowley, Michel Vandermael, Eric J. Topol et al. · Journal of the American College of Cardiology · 1993 · 60 citations

Medicine, Cardiology, Surgery +16

Determinants of 2-year outcome after coronary angioplasty in patients with multivessel disease on the basis of comprehensive preprocedural evaluation. Implications for patient selection. The Multivessel Angioplasty Prognosis Study Group.

Stephen G. Ellis, Michael J. Cowley, Germano DiSciascio et al. · Circulation · 1991 · 57 citations

Medicine, Cardiology, Cardiothoracic Surgery +16

Lisinopril Versus Placebo in the Treatment of Heart Failure: The Lisinopril Heart Failure Study Group

Barry M. Beller, Thomas M. Bulle, Robert C. Bourge et al. · The Journal of Clinical Pharmacology · 1995 · 22 citations

Medicine, Cardiology, Pharmacology +12